Lewis rats, EAE (SCH) |
6-weeks male |
66% CR for 15 days pre-induction |
↓ clinical score |
↓ spleen & lymph IFN-γ |
Esquifino et al. 2007 [132] |
SJL mice, EAE (PLP) |
5-weeks female |
40% CR for 5 weeks pre-induction |
↓ clinical score; ↑ survival; ↓ spinal cord inflammation, demyelination, & axon damage |
↑ corticosterone & adiponectin; ↓ leptin & IL-6 |
Piccio et al. 2008 [133] |
C57BL/6 mice, EAE (MOG) |
13-weeks female |
ADF for 8 weeks pre-induction, post-induction, or both |
↓ incidence (ADF post) |
N/A |
Kafami et al. 2010 [134] |
C57BL/6 mice, EAE (MOG) |
10-weeks female |
FMD (3 cycles) at 10% symptomatic (S), at 100% symptomatic (T), or at 2 weeks post-symptoms (C-F) |
↓ clinical score (all); ↓ incidence (S); ↓ spinal cord inflammation & demyelination (T); ↑ myelin regeneration (T) |
↓ blood WBC, lymphocytes, monocytes, & granulocytes; ↓ CNS CD4 & CD8 T-cells; ↑ spleen naïve:active CD4 T-cell ratio (T) |
Choi et al. 2016 [136] |
C57BL/6 mice, EAE (MOG) |
7-weeks female |
ADF for 4 weeks pre-induction |
↓ clinical score; ↓ spinal cord inflammation & demyelination; |
↓ lymph T-cell IL-17 & IFN-γ; ↑ corticosterone & BHB; ↑ T-regs in small intestine |
Cignarella et al. 2018 [135] |
C57BL/6 mice, EAE (MOG) |
8 weeks-female |
ADF for 4 weeks pre-induction |
↓ clinical score |
↓ blood & CNS inflammatory monocytes; ↓ CNS monocyte TNFα, IL-1β, CXCL2 &CXCL10 |
Jordan et al. 2019 [55] |
C57BL/6 mice, EAE (MOG) |
6-weeks female |
FMD (2 cycles) at 3 weeks post-induction |
↓ incidence; ↓ clinical score; ↓ spinal cord inflammation & demyelination; ↑ myelin regeneration |
↓ spinal cord leukocytes & macrophages; ↓ CNS CD4 & CD8 T-cells; ↓ CNS T-cell IL-17 &↑ IFN-γ; ↑ spleen CD4 & CD11b T-cells |
Bai et al. 2021 [137] |
2 Multiple Sclerosis Human Studies
|
Patient Population
|
Age & Sex
|
Dietary Interventions
|
Clinical Findings
|
Immune & Biomarkers
|
Reference
|
Adult RRMS patients |
18–68 (mean: 45) male & female |
1-cycle of FMD followed by a Mediterranean diet (n = 18), KD (n = 18), or control diet (n = 12) for 6 months |
↑ QOL (FMD & KD) |
n/s |
Choi et al. 2016 [136] |
Adult RRMS patients undergoing relapse |
18–60 (mean: 41) male & female |
<500 kcal ADF (n = 8) or control diet (n = 8) for 15 days |
n/s |
↓ blood T&B cells; ↓ naïve CD4 T-cells; ↓ Leptin |
Cignarella et al. 2018 [135] |
Adult RRMS patients not undergoing relapse |
18–50 (mean: 37) male & female |
75% CR 5:2 IF (n = 11), 22% CR (n = 11), or control diet (n = 9) for 8 weeks |
n/s |
↓ memory T-cells and Th1 cells ↑ naïve CD4 T-cells |
Fitzgerald et al. 2022 [138] |